Popularity of less frequent follow up for breast cancer in randomised study: initial findings from the hotline study

Gulliford, T.; Opomu, Magi; Wilson, Elena; Hanham, I. W. F.; Epstein, Richard J.

doi:10.1136/bmj.314.7075.174

Cited by 124 publications

(130 citation statements)

References 22 publications

Supporting

Mentioning

123

Contrasting

Unclassified

Order By: Relevance

“…From these abstracts, six full-length articles were obtained, all of which were eligible for inclusion in the analysis (Grunfeld et al, 1996Gulliford et al, 1997;Brown et al, 2002; Koinberg et al, 2004; Kokko et al, 2005). One abstract had been published as part of the proceedings of a scientific meeting and the data had not yet been published in full (Baildam et al, 2004).…”

Section: Resultsmentioning

confidence: 99%

“…Moreover, similar numbers in the high-and low-frequency groups will express a desire for lower-or higher-frequency visits than they received during the trial (Gulliford et al, 1997). In the trial by Baildam et al (2004), the Fallowfield Satisfaction with Consultation Questionnaire revealed that women were significantly more satisfied with their consultation with a nurse than those seen by a doctor (Po0.001).…”

Section: Satisfactionmentioning

confidence: 93%

“…Two trials compared follow up in hospital clinics with that provided by a general practitioner (Grunfeld et al, 1996, two compared traditional follow up with follow up merely on demand by contacting a breast care nurse (Brown et al, 2002;Koinberg et al, 2004) and one compared routine follow up by doctors with routine follow up by breast care nurses (Baildam et al, 2004). Two trials compared different frequencies of follow up within a traditional framework (Gulliford et al, 1997;Kokko et al, 2005).…”

Section: Study Characteristicsmentioning

confidence: 99%

“…It is unclear whether further increasing follow up interval to annual would have an effect on detection of local recurrence. One study attempted to address this issue, but recruited only 196 patients and analysed after a median of 16 months follow up, so had insufficient patient numbers and follow-up duration to conduct such analysis (Gulliford et al, 1997).…”

Section: Detection Of Recurrencementioning

confidence: 99%

“…Within a traditional follow-up schedule, frequency can be reduced with no loss of satisfaction (Gulliford et al, 1997). Moreover, similar numbers in the high-and low-frequency groups will express a desire for lower-or higher-frequency visits than they received during the trial (Gulliford et al, 1997).…”

Section: Satisfactionmentioning

confidence: 99%

See 4 more Smart Citations

Alternative methods of follow up in breast cancer: a systematic review of the literature

2007

View full text Add to dashboard Cite

Regular clinical follow up after breast cancer is a common practice. Evidence from retrospective reviews casts doubt on the efficacy of this practice and the various guidelines for follow up show little concordance. Our aim was to investigate what alternative follow-up methods (including reduced frequency of visits) have been subjected to controlled trial and to establish what evidence exists from controlled trials to advise the guidelines. The study involved systematic review of the literature using MEDLINE, Embase, CancerLit, Web of Sciences and EBM reviews as data sources. Methods included reviewing all randomised controlled trials comparing different follow-up frequencies or comparing an alternative method with clinical follow up after breast cancer. All outcome measures addressed in the trials were analysed. Two trials compared frequency of traditional follow up. Five trials assessed alternative methods. All were of inadequate power or duration to establish ideal frequency of clinic visits or safety of alternative follow-up methods. Alternative follow up had no detrimental effect on satisfaction or outcome. Few trials have been conducted, all of which are underpowered to establish safety of reducing or replacing clinic visits. Alternative methods of follow up are acceptable to patients and may be associated with other benefits. Larger trials are required.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Satisfactionmentioning

confidence: 93%

Section: Study Characteristicsmentioning

confidence: 99%

Section: Detection Of Recurrencementioning

confidence: 99%

Section: Satisfactionmentioning

confidence: 99%

See 3 more Smart Citations

Alternative methods of follow up in breast cancer: a systematic review of the literature

2007

View full text Add to dashboard Cite

show abstract

Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumors

et al. 2018

View full text Add to dashboard Cite

There is no consensus on optimal follow-up for completely resected gastroenteropancreatic neuroendocrine tumors. Published guidelines for follow-up are complex and emphasize closer surveillance in the first 3 years after resection. Neuroendocrine tumors have a different pattern and timescale of recurrence, and thus require more practical and tailored follow-up. The Commonwealth Neuroendocrine Tumour Collaboration convened an international multidisciplinary expert panel, in collaboration with the North American Neuroendocrine Tumor Society, to create patient-centered follow-up recommendations for completely resected gastroenteropancreatic neuroendocrine tumors. This panel used the RAND/UCLA (University of California, Los Angeles) Appropriateness Method to generate recommendations. A large international survey was conducted outlining current the surveillance practice of neuroendocrine tumor practitioners and shortcomings of the current guidelines. A systematic review of available data to date was supplemented by recurrence data from 2 large patient series. The resultant guidelines suggest follow-up for at least 10 years for fully resected small-bowel and pancreatic neuroendocrine tumors and also identify clinical situations in which no follow-up is required. These recommendations stratify follow-up strategies based on evidence-based prognostic factors that allow for a more individualized patient-centered approach to this complex and heterogeneous malignant neoplasm.

show abstract

Follow-up strategies for women treated for early breast cancer

Rojas

Telaro

Moschetti

et al. 2000

Cochrane Database of Systematic Reviews

112

View full text Add to dashboard Cite

Popularity of less frequent follow up for breast cancer in randomised study: initial findings from the hotline study

Cited by 124 publications

References 22 publications

Alternative methods of follow up in breast cancer: a systematic review of the literature

Alternative methods of follow up in breast cancer: a systematic review of the literature

Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumors

Follow-up strategies for women treated for early breast cancer

Contact Info

Product

Resources

About